HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

rhIL-11

TERMINATED · PHASE1 · Ulcerative Colitis, Inflammatory Bowel Disease

Unknown stopping reason

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.